Skip to Content
Merck

GCxGC Analysis of FAMEs in Human Plasma on Equity-1 x SUPELCOWAX 10, Non-Polar to Polar Strategy

GCxGC Analysis of FAMEs in Human Plasma on Equity-1 x SUPELCOWAX 10, Non-Polar to Polar Strategy suitable for GC

Materials

analytical column

Product No.
Description
Pricing

Equity-1 Capillary GC Column

L × I.D. 30 m × 0.25 mm, df 0.25 μm

CONDITIONS

column

(1D) Equity 1, 30 m x 0.25 mm I.D., 0.25 μm (28406-U)

column

(2D) SUPELCOWAX 10, 0.95 m x 0.10 mm I.D., 0.10 μm (24343)

oven

180 °C, 3 °C/min to 280 °C (10 min)

oven

(modulator) LMCS Everest longitudinally modulated cryogenic system, modulation period 6 sec

inj. temp.

280 °C

detector

FID, 300 °C, 125Hz; MS, 20000 amu/sec

carrier gas

hydrogen

sample

human plasma

Description

General description

The 0.95 m SUPELCOWAX 10 column was obtained by cutting lengths from a standard length column (e.g. 5, 10, 15 m).

Analysis Note

Sample prep: 100 mL of plasma was saponified with 1 mL of methanolic sodium methoxide (0.5% w/v) at a temperature of 100 °C for 15 min in a closed Pyrex tube. The subsequent methylic esterification was achieved with 1 mL boron trifluoride-methanol complex at a temperature of 100 °C for 15 min. The fatty acid methyl esters (FAMEs) were extracted by adding 1 mL of n-hexane to the mixture. One mL of a saturated NaCl solution was added to the entire mixture, which was then agitated manually for 2 min, followed by centrifugation at 3000 rpm for 10 min. After, anhydrous Na2SO4 was added to the Pyrex tube for drying and 0.9 mL of the n-hexane FAME layer was transferred to a GC injector vial. A 0.1 mL volume of 1000 ppm internal standard (C13:0) was also added to the GC vial.

Legal Information

null
null